(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -110.03%-613.29K | 12.92%3.15M | 231.70%458.88K | 173.78%2.27M | 128.08%125.67K | -130.72%-292.01K | 72.79%2.79M | 93.29%-348.44K | -140.58%-3.08M | 88.87%-447.6K |
Net income from continuing operations | 79.21%-522.1K | 319.61%1.21M | -95.03%27.01K | 133.21%1.37M | 328.31%3.89M | -581.42%-2.51M | 87.52%-550.12K | 305.52%543.8K | -117.43%-4.13M | -77.79%908.37K |
Operating gains losses | -114.61%-68.5K | 130.31%141.05K | -1,965.84%-463.74K | -34.70%-2.53M | -424.78%-2.51M | 152.65%468.88K | -4,314.95%-465.33K | 95.70%-22.45K | 80.93%-1.88M | -108.73%-479K |
Depreciation and amortization | 5.89%22.68K | 4.64%21.8K | 2.82%21.42K | 1.98%84.49K | 2.82%21.42K | 3.59%21.42K | 0.75%20.83K | 0.75%20.83K | 103.38%82.85K | 40.74%20.83K |
Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 74.38%-34.58K | ---- | ---- |
Unrealized gains and losses of investment securities | -96.42%60.37K | -170.72%-786.39K | 121.32%170.72K | -64.41%1.3M | 22.48%-703.17K | 271.92%1.69M | -69.08%1.11M | -261.38%-800.89K | 754.86%3.64M | -121.72%-907.07K |
Remuneration paid in stock | --0 | ---- | ---- | 290.80%256.93K | --0 | --218.82K | ---- | ---- | --65.75K | --31.02K |
Other non cashItems | 47.99%-56.3K | 23.03%-108.45K | 20.40%-111.45K | -12.22%-536.24K | 77.43%-147.08K | ---108.25K | ---140.9K | ---140.01K | -72.92%-477.84K | -18.35%-651.71K |
Change In working capital | 28.14%-49.44K | -2.45%2.67M | 860.31%814.93K | 722.84%2.33M | -167.05%-422.41K | -105.03%-68.8K | 13.22%2.74M | 101.77%84.86K | 94.21%-374.15K | 109.08%629.96K |
-Change in receivables | -38.42%-197.47K | 15.25%3.11M | 58.09%230.32K | 18.55%2.38M | -152.74%-320.25K | -111.13%-142.67K | 8.80%2.7M | 106.17%145.69K | 122.47%2.01M | 106.74%607.21K |
-Change in prepaid assets | 98.75%34.41K | -70.18%16.52K | -9.70%-81.22K | -147.19%-9.03K | -157.67%-7.71K | -54.74%17.31K | 1,037.14%55.4K | -178.45%-74.03K | -53.23%19.13K | 228.51%13.38K |
-Change in payables and accrued expense | 113.47%120.72K | -4,752.07%-666.82K | 4,943.68%665.82K | 98.40%-38.43K | -1,106.87%-94.44K | 17.39%56.55K | 74.48%-13.74K | 100.55%13.2K | -199.01%-2.4M | -99.55%9.38K |
-Change in other working capital | ---7.1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -110.03%-613.29K | 12.92%3.15M | 231.70%458.88K | 173.78%2.27M | 128.08%125.67K | -130.72%-292.01K | 72.79%2.79M | 93.29%-348.44K | -140.58%-3.08M | 88.87%-447.6K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 130.84%121.9K | -111.25%-56.43K | 53.12%-71.93K | 185.46%3.25M | 164.76%3.29M | -1,138.91%-395.28K | 54.69%501.69K | -116.60%-153.44K | 3.10%-3.8M | -27.44%-5.09M |
Net PPE purchase and sale | 90.42%-11.76K | --0 | ---5.06K | -18.10%-186.53K | 17.13%-63.86K | ---122.66K | --0 | --0 | 62.23%-157.94K | -197.49%-77.07K |
Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --246.06K | ---- |
Net investment purchase and sale | 83.56%-26.35K | -112.60%-56.43K | 56.42%-66.87K | 188.32%3.43M | 162.65%3.3M | -416.40%-160.28K | 36.38%447.98K | -115.35%-153.44K | -16.88%-3.89M | -35.35%-5.27M |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | -791.06%-112.35K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 130.84%121.9K | -111.25%-56.43K | 53.12%-71.93K | 185.46%3.25M | 164.76%3.29M | -1,138.91%-395.28K | 54.69%501.69K | -116.60%-153.44K | 3.10%-3.8M | -27.44%-5.09M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -155.92%-230.33K | 441.74%360.85K | 85.01%-58.57K | -1,139.76%-422.69K | 45.81%-8.63K | -523.04%-90K | 279.13%66.61K | -2,303.46%-390.67K | 138.87%40.65K | 73.53%-15.92K |
Net common stock issuance | -155.92%-230.33K | 67.45%-24.85K | 85.01%-58.57K | -1,446.65%-565.64K | 45.81%-8.63K | ---90K | -604.83%-76.34K | -3,878.35%-390.67K | 73.67%-36.57K | 79.44%-15.92K |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | 85.11%142.95K | --0 | --0 | ---- | ---- | -8.39%77.23K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -155.92%-230.33K | 441.74%360.85K | 85.01%-58.57K | -1,139.76%-422.69K | 45.81%-8.63K | -523.04%-90K | 279.13%66.61K | -2,303.46%-390.67K | 138.87%40.65K | 73.53%-15.92K |
Net cash flow | ||||||||||
Beginning cash position | 161.35%10.4M | 993.69%6.95M | 332.51%6.61M | -81.65%1.53M | -70.48%3.21M | -59.56%3.98M | -91.92%635.7K | -87.39%1.53M | 74.54%8.33M | -33.67%10.88M |
Current changes in cash | 7.15%-721.72K | 2.86%3.45M | 136.79%328.39K | 174.53%5.1M | 161.46%3.41M | -176.97%-777.29K | 71.64%3.35M | 79.01%-892.56K | -292.13%-6.84M | 31.23%-5.55M |
Effect of exchange rate changes | -122.08%-2.56K | 44.34%-6.73K | 2,814.73%12.35K | -135.10%-12.84K | -56.63%-11.87K | -66.87%11.58K | -169.70%-12.1K | 94.43%-455 | 2,692.13%36.58K | -120.58%-7.58K |
End cash Position | 201.10%9.67M | 161.35%10.4M | 993.69%6.95M | 332.51%6.61M | 332.51%6.61M | -70.48%3.21M | -59.56%3.98M | -91.92%635.7K | -81.65%1.53M | -81.65%1.53M |
Free cash from | -50.73%-625.04K | 12.92%3.15M | 230.24%453.83K | 164.41%2.08M | 111.78%61.81K | -143.62%-414.67K | 72.79%2.79M | 93.39%-348.44K | -145.83%-3.24M | 86.69%-524.66K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data